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Substrate speciﬁcitya b s t r a c t
The substrate speciﬁcity of recombinant human mitochondrial intermediate peptidase (hMIP) using
a synthetic support-bound FRET peptide library is presented. The collected ﬂuorescent beads, which
contained the hydrolysed peptides generated by hMIP, were sequenced by Edman degradation. The
results showed that this peptidase presents a remarkable preference for polar uncharged residues at
P1 and P10 substrate positions: Ser = Gln > Thr at P1 and Ser > Thr at P10. Non-polar residues were fre-
quent at the substrate P3, P2, P20 and P30 positions. Analysis of the predicted MIP processing sites in
imported mitochondrial matrix proteins shows these cleavages indeed occur between polar
uncharged residues. Previous analysis of these processing sites indicated the importance of posi-
tions far from the MIP cleavage site, namely the presence of a hydrophobic residue (Phe or Leu)
at P8 and a polar uncharged residue (Ser or Thr) at P5. To evaluate this, additional kinetic analyses
were carried out, using ﬂuorogenic substrates synthesized based on the processing sites attributed
to MIP. The results described here underscore the importance of the P1 and P10 substrate positions
for the hydrolytic activity of hMIP. The information presented in this work will help in the design of
new substrate-based inhibitors for this peptidase.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction inter-membrane space or mitochondrial matrix. Most of the pro-Most mitochondrial proteins are encoded by nuclear DNA and
produced by ribosomes outside this organelle [1]. Numerous pro-
teins directed to the mitochondrial matrix, intermembrane space
or internal membrane are synthesized with an extended
N-terminus, a signal sequence, which is cleaved-off by speciﬁc
mitochondrial peptidases [2]. The mitochondrial processing pepti-
dase (MPP; EC 3.4.24.64) is the most important processing enzyme
that acts on proteins directed to the inner membrane,teins targeted to the mitochondrial matrix or inner membrane pre-
sent a single cleavage by MPP. However, in the mitochondrial
matrix, some proteins also take a second sequential cleavage by
the mitochondrial intermediate peptidase (MIP; EC 3.4.24.59). In
these proteins, MIP removes eight residues from the newly gener-
ated N-terminus after the MPP action [3–6].
Human MIP (hMIP) is encoded by a nuclear gene (MIPEP), and is
transported to the mitochondria. It also presents a signal sequence
of 35 residues that is cleaved by MPP. MIP is a soluble monomer of
about 75 kDa with the typical zinc ion binding motif, HEXXH [7].
The higher levels of hMIP expression were detected in tissues that
consume oxygen at a high rate, i.e. in heart and skeletal muscle,
and in several regions of the brain [8]. This peptidase was identi-
ﬁed in many mammals and other species too [5,9–12]. The enzyme
from Saccharomyces cerevisiae, formerly known as yeast mitochon-
drial intermediate peptidase (yMIP) but now called octapeptidyl
amino peptidase 1 (oct1), is the best characterized mitochondrial
intermediate peptidase. According to the N-terminal end rule, the
action of oct1 is important to the stability of the oct1 processed
proteins in the mitochondrial matrix [13,14]. This hypothesis
arises from the observations of the amino terminal sequences from
the processed proteins by this enzyme, before and after the oct1
action, and, from the direct analysis of the stability of three known
430 M.F.M. Marcondes et al. / FEBS Open Bio 5 (2015) 429–436oct1 processed proteins in a Doct1 S. cerevisiae [14]. Thus, oct1
converts unstable precursor intermediates generated by MPP into
stable mature proteins. This same function of stabilizing proteins,
because of removal of a N-terminal residue in proteins imported
to mitochondrial matrix, has also been proposed for the recently
identiﬁed amino peptidase lcp55 [15]. Using proteomic approaches
directed to yeast mitochondrial N-terminal sequences, the authors
showed that this amino peptidase also acts after MPP processing,
by removing one amino acid residue from the newly generated
N-terminal. Therefore, some proteins are processed in two steps:
the ﬁrst by MPP followed by oct1 or ﬁrst by MPP but followed by
lcp55. There is also the possibility that some proteins undergo a
three step processing MPP-lcp55-oct1, or MPP-oct1-oct1 [13,15].Table 1
Substrate preference matrix for hMIP.
Analysis of the frequencies for speciﬁc residues at each identiﬁed position in the sequences of peptides hydrolysed in
the support-bound FRET peptide library screening. Based on the 20 sequences shown in Table S1. The bottom rows
indicate the total number of residues analyzed for each speciﬁc position. The background grey scale helps to bring
attention to the higher numbers.We recently reported the expression, puriﬁcation and the par-
tial characterization of recombinant human MIP in Escherichia coli,
and presented the ﬁrst continuous activity assay for this peptidase,using the ﬂuorogenic substrate Abz-GFSPFRQ-EDDnp [16]. Only a
small level of inhibition was detected with thiorphan (a neprilysin
inhibitor) [17] captopril (an angiotensin-converting enzyme inhi-
bitor) [18] and JA-2 (a thimet oligopeptidase inhibitor) [19].
These results exclude hMIP as a target of these inhibitors that are
used widely to measure TOP (thimet oligopeptidase), ACE
(angiotensin-converting enzyme) or NEP (neprilysin) enzymatic
activity in cells, tissue sample extracts, and also for in vivo inhibi-
tion assays. These metallopeptidase inhibitors bear a substrate
mimetic portion containing a zinc binding group as warhead. A
good understanding of the substrate speciﬁcity of hMIP can guide
the design of new selective inhibitors containing this zinc binding
group as warhead.Knowledge about the substrate speciﬁcity of peptidases is
essential to identify their roles in mammalian organisms and to
aid in the development of selective assays. FRET substrates are
Table 2
Kinetic parameters for the hydrolysis of FRET peptides by hMIP.
Sequence No. Substrate kcat (s1) KM (lM) kcat/KM (mM1 s1)
1 Abz- VAA;QTKTK(Dnp)-NH2 0.050 10 5.0
2 Abz-WT;TGGKAK(Dnp)-NH2 0.0033 6.2 0.53
4 Abz-MT ;AALK; TK(Dnp)-NH2 0.19a 4.2a 45a
5 Abz- IKQ;SSLLK(Dnp)-NH2 0.055 1.1 50
6 Abz-NLM;KKSTK(Dnp)-NH2 0.028 1.3 22
8 Abz- FS;SKTTVK(Dnp)-NH2 0.036 1.3 28
10 Abz-VIS;SRLEK(Dnp)-NH2 0.083 1.9 44
12 Abz- TTKL; K; A;AK(Dnp)-NH2 0.070a 0.85a 82a
14 Abz- FQ;TKVAAK(Dnp)-NH2 0.057 3.4 17
The substrates were synthesized based on the sequences identiﬁed in the support-bound FRET peptide library screening. The
parameters were calculated as mean value ± SD, which was lower than 10%. ; indicates the cleavage site.
a Apparent constants determined by following the total product formation.
Table 3
Substrate preference matrix for hMIP.
Analysis of the frequencies for speciﬁc residues, at each position, in the sequences of predicted MIP processing sites
at the newly generated N-terminal by the MPP action on nuclear encoded proteins imported to the mitochondrial
matrix [25]. Based on the 19 sequences shown in Table S3. The background grey scale helps to bring attention to the
higher numbers.
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important step for the development of speciﬁc inhibitors.
Because MIP activity contributes to the mitochondrial iron uptake
it has been proposed that the inhibition of MIP might decrease the
mitochondrial iron accumulation, a disease known as Friedreich’s
ataxia, and this could attenuate some complications of this neu-
rodegenerative disease [20].
In the present work, we studied the substrate speciﬁcity of
recombinant human MIP (hMIP), using the synthetic support bond
FRET peptide library approach. This support-bound FRET peptide
library was prepared on polyethylene glycol dimethyl acrylamide
copolymer (PEGA) beaded resin by the process of split-combine
synthesis, which results in a single peptide sequence on each bead
[21–24]. Seven positions (X1–X7) were randomized using all 20
genetically encoded amino acids. FRET peptides when hydrolysed
by the peptidase turned the bead ﬂuorescent and these beads were
manually picked, the remaining peptide was sequenced by Edman
degradation methodology. In this approach the enzymatic reaction
is terminated before complete hydrolysis of all the peptide
attached to a single bead, so each bead contained both the com-
plete peptide sequence as well as the sequences of the remaining
portion of the cleaved peptide (S0 amino acids). Thus, is possible
to obtain the peptide sequence and the cleavage site using this
experimental approach.Fig. 1. Analysis of the frequencies for speciﬁc residues, at each identiﬁed position, in
screening in comparison with the hydrolysis of the FRET substrates in the solutio
MIP [25] .9 identiﬁed peptides using this approach were synthesized, the
hMIP cleavage sites and the kinetic parameters evaluated.
Additional kinetic analyses were also carried out, using synthetic
ﬂuorogenic substrates based on the processing sites attributed to
MIP for the precursor nuclear encoded proteins. The data of these
substrates gave further insights into the hMIP substrate speciﬁcity.
2. Results and discussion
2.1. Support-bound FRET peptide library screening
The results of the Edman degradation analysis of the ﬂuorescent
beads collected in the synthetic support-bound FRET peptide
library screening with hMIP are shown in Table S1. The results of
this assay clearly showed that MIP hydrolysed preferentially the
peptides presenting uncharged polar residues at both P1 and P10
positions, especially Ser, Thr and Gln (Tables S1, S2 and Table 1).
Thr and Ser are also the preferred residues found in the P20 position
(Table 1). Beyond the clear preference for uncharged polar residues
at positions P1, P10 and P20, some other determinants of speciﬁcity
were also observed for hMIP in the assays: hMIP prefers nonpolar
residues at the P3, P2, and P30 substrate positions (Table 1).
However, the occurrence of the basic residue Lys at position P20
and P30 is signiﬁcant (Table 1).the sequences of peptides hydrolysed in the support-bound FRET peptide library
n , and the sequences based on proteins with conﬁrmed two-step cleavage by
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tide library screening 9 new FRET substrates were synthesized.
The sequences are shown in Table 2, these FRET substrates were
assayed in solution with hMIP, and the kinetic parameters for the
hydrolysis reactions are presented in Table 2. All substrates were
hydrolysed by hMIP; 5 of them at the same site as it occurred in
the solid-phase support, but 4 were cleaved at a different site or
presented additional cleavages by MIP. However, despite these dif-
ferences between the cleavage sites observed after the kinetic
assays in the FRET substrates and the cleavage sites detected in
the support bound peptide only the substrates 6 and 12 were not
hydrolysed with uncharged polar residues at P1 or P10.
For the substrates 4 and 12 more than one cleavage site were
detected (Table 2), analysis of product formation in time using
HPLC revealed that for the both substrates the peaks corresponding
to the products appears simultaneously indicating that no subse-
quent cleavage of the products occurs. These data together withTable 4
Substrate preference matrix for oct1.
Analysis of the frequencies for speciﬁc residues at each positi
the newly generated N-terminal by the MPP action on n
mitochondrial matrix [14]. Based on the 14 sequences show
attention to the higher numbers.a description that MIP can act on some FRET substrates described
for the thimet oligopeptidase (TOP) and neurolysin (NEL) [16],
oligopeptidases that are members of MIP peptidase family, shows
that MIP is able to act on peptides releasing products with different
lengths, not only 8-mer peptides. A possible explanation for those
observations is that when acting on the N-terminal of large pro-
teins MIP probably presents some ruler-like interaction but when
small substrates are free to ﬁnd their way into the MIP active site
fewer interactions seems to be necessary to the formation of a pro-
ductive enzyme-substrate complex. Unfortunately this characteris-
tic of MIP cannot be interpreted in details, since the 3D structure of
MIP has not been determined so far.
Therefore, also in the case of these small substrates in solution,
which are free to access the hMIP extended substrate binding site
with multiple possibilities of interaction it can be observed that
uncharged polar residues are preferred at P1 and/or P10 substrate
positions (Table 2).on in the sequences of predicted oct1 processing sites at
uclear encoded proteins imported to the S. cerevisiae
n in Table S4. The background grey scale helps to bring
Table 5
Kinetic parameters for the hydrolysis of FRET peptides by hMIP.
Substrate kcat
(s1)
KM
(lM)
kcat/KM
(mM1 s1)
Abz-VRNFRSGQPLQ;NKVQ-
EDDnp
0.223 1.80 124
Abz-FRSGQPLQ;NKVQLQ-EDDnp 0.122 0.941 130
Abz-QPLQ;NKVQ-EDDnp 0.061 2.9 21
Abz-QPLA;NKVQ-EDDnp 0.0570 5.1 11
Abz-QPLQ;AKVQ-EDDnp 0.0943 3.2 29
The parameters were calculated as mean value ± SD, which was lower than 10%. ;
indicates the cleavage site.
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Joseph et al. analyse the sequences of proteins known as sub-
strates for MIP and identiﬁed some conserved positions [25], with
respect to the cleaved bond. These conserved positions are F/L/I at
P8 and T/S/G at P5. Reanalysing both predicted and conﬁrmed MIP
cleavage sites on 19 precursor proteins, we noted that 14 (>70%) of
them have polar uncharged residues at P1 and/or the P10 positions
[25] (Table 3 and Table S3), results in line with the outcome of the
support-bound FRET peptide library presented above (Table 1).
The substrate binding preference of the P3–P30 sites of MIP are
presented in the Fig. 1, based on the data obtained from the syn-
thetic support-bound FRET peptide library, the hydrolysis of the
9 small FRET substrate in solution, and the sequences of precursor
proteins that have conﬁrmed the second step of cleavage by MIP
[25] (Table S3). This analysis corroborates the preference for non-
polar residues at the P2 position; the occurrence of nonpolar or
basic residues at the P20, detected in the support-bound FRET pep-
tide analysis, and the clear preference for uncharged polar residues
at positions P1 and P10 (Fig. 1).
Recently MIP processing sites were studied in details for yeast
mitochondria imported proteins [14]. This study revealed impor-
tant observations about the yeast MIP – the so-called oct1 – to
light. Table 4 shows the MPP processing sites together with the
MIP processing sites in 14 mitochondrial yeast proteins. Again
F/L at the position 8 and T/S at 5 seem to be determinants to
MPP/MIP activities (Table 4 and Table S4). Furthermore, Isaya
et al. described additional evidences that hydrophobic amino acid
positioned near the N-terminal residues are crucial for MIP activity
[26].
The results described here support the knowledge that MIP can
act on small FRET substrates [16] and the importance for the P1
and P10 substrate residues, close to the hydrolysed peptide bond.
However the impact of this F/L/I at P8 and T/S/G at P5 positions on
the ability of MIP to process small peptides its unknown. To investi-
gate this, we synthesized 2 FRET substrates containing the
sequences of precursor proteins – assumed to be hydrolysed by
MIP – mimicking the predicted processing sites, Abz-FRSGQP
LQNKVQLQ-EDDnp (human ornithine transcarbamylase) and
Abz-VRTLTINK_EDDnp (yeast pyruvate dehydrogenase E3
subunit). Both substrates were cleaved at the same
predicted site, Abz-FRSGQPLQ;NKVQLQ-EDDnp and Abz-VRTL;
TINK_EDDnp, however in the yeast sequence there is no P8 nor Thr
or Ser at P5. The substrateAbz-FRSGQPLQNKVQLQ-EDDnp is thebest
substrate for hMIPwith better speciﬁcity constant due to the higher
catalytic constant value (kcat/KM = 130 mM1 s1 and kcat = 0.122 -
s1), when compared with kinetic parameters of
Abz-VRTLTINK_EDDnp (kcat/KM = 27 and kcat = 0.0093). No signiﬁ-
cant difference on the afﬁnity constant values (KM) was observed,
0.941 mM1 and 0.35 mM1 respectively.
Based on this observation, some variations of the
human ornithine transcarbamylase based substrate, Abz-FRSG
QPLQNKVQLQ-EDDnp, were prepared and assayed with hMIP.
These variants were synthesized with the purpose to analyse the
importance of the substrate length, especially the impact of both
P5 and P8 positions, and also the importance of the residues at P1
and/or P10 positions. Furthermore, these new variants could be an
interesting starting point for the development of new speciﬁc
FRET substrates for MIP activity detection assays. The data of these
new substrates, the results of cleavage site and kinetic parameters
are presented in Table 5. The kinetic assays with the variants of the
Abz-FRSGQPLQNKVQLQ-EDDnp gave all similar results. The smal-
ler variants Abz-QPLQNKVQ-EDDnp, Abz-QPLANKVQ-EDDnp and
Abz-QPLQAKVQ-EDDnp, were all cleaved at the same site.
However, the analogue Abz-QPLQNKVQ-EDDnp, without the P8
and P5, was hydrolysed with a 7-fold lower speciﬁcity constantthan Abz-FRSGQPLQNKVQLQ-EDDnp (Table 5). Almost no signiﬁ-
cant difference in the kcat values and KM constants were observed
when the P1 or the P10 polar residues were replaced by an Ala resi-
due (Table 5). Thus the preference of hMIP for the polar uncharged
residues at these positions is not absolute, an observation in line
with the analysis of the predicted MIP processing sites (Table 3),
the presence of other residues, specially Ala, are found in the MIP
cleavage site, in some processed proteins (Table 3 and Table S3).
3. Conclusions
The hMIP substrate speciﬁcity was ﬁrst investigated using syn-
thetic support-bound FRET peptide library screening, the results
obtained in this entire randomized approach revealed the hMIP
preferences for substrate residues close to the hydrolysed peptide
bond, with a clear preference for uncharged polar residues at posi-
tions P1 and P1 and nonpolar residues at the substrate P3, P2, P20 and
P30 positions, matching exactly the analysis of the cleavage sites
predicted to be natural substrates for hMIP.
The results of the speciﬁcity analysis using FRET substrates
based on natural substrates, support the information that hMIP
can act upon small substrates, as well as that for recognition and
processing small peptides the most important conserved position
(F/L/I at P8 and T/S/G at P5) are not crucial, as in the case of the
action by hMIP on the N-terminal of large proteins. This observa-
tion together with the distinct substrate speciﬁcity presented by
hMIP, specially its preference for polar uncharged residues at P1
and P10 positions, can be important information for the develop-
ment of substrates and inhibitors speciﬁc for hMIP.
4. Experimental procedures
4.1. Construction of the expression vector
The hMIP cDNA fragment (2000 bp) was ampliﬁed by PCR
using the clone, ID 4053687, from the Mammalian Gene
Collection (MGC) of Invitrogen. The construct pET28-MIP, which
produces hMIP with a hexahistidine tag at its N-terminus instead
of the residues that correspond to the mitochondrial signal
sequence, has already been previously described by our group [16].
4.2. Expression of recombinant hMIP
E. coli BL21 (DE3) pLysS (Novagen) was used as the expression
host. E. coli cells were incubated overnight at 30 C and shaken at
150 rpm in 10 mL of Luria-broth (LB) medium, containing kanamy-
cin (50 lg/mL) and chloramphenicol (50 lg/mL). These cells were
transferred to 1 L of fresh LB medium at 30 C and 150 rpm, until
the culture density reached 0.4 OD550. The temperature was then
reduced to 20 C and when the culture density reached 0.6–0.7
OD550 isopropyl b-D-1-thiogalactopyranoside (IPTG) was added to
a ﬁnal concentration of 0.1 mM. After 14–16 h, the bacterial cells
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The pellet was stored at 70 C.
4.3. Puriﬁcation of the recombinant hMIP
The pellet was resuspended in 20 mL binding buffer (50 mM
NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0), and lysozyme
(1 mg/mL). This suspension was put on ice for 30 min and then
RNase and DNase (to a ﬁnal concentration of 5 lg/mL each), and
2 mL of 0.2% Triton X-100 were added. The resultant mixture
was centrifuged at 15,000 rpm for 20 min and the supernatant
was recovered.
The supernatant was loaded at a ﬂow rate of 0.5 mL/min on a
Ni-Sepharose high performance chromatography column (GE
Healthcare) previously equilibrated with binding buffer. The col-
umn was washed with 5 ml of binding buffer, and the recombinant
hMIP was eluted, using a segmented step elution with increasing
imidazole concentrations (50, 100, 150 and 500 mM) in binding
buffer (20 mM NaH2PO4 pH 8.0, 500 mM NaCl). The recombinant
protein eluted between 100 and 150 mM imidazole. Fractions of
8–10 mL each, were collected and loaded onto a desalting
preparatory column (GE Healthcare), and the fractions containing
hMIP were recovered.
This desalted samples were loaded at a ﬂow rate of 1.0 mL/min
on a resource Q column (1 mL) previously equilibrated with TB
buffer (50 mM Tris, pH 7.4). After an initial washing with 6 mL of
TB buffer, the elution was performed with 40 mL of a linear gradi-
ent with TBS buffer (50 mM Tris–HCl, pH 7.4, 500 mM NaCl).
Recombinant hMIP eluted between 80 and 200 mM NaCl. The frac-
tions containing homogeneous (SDS–PAGE) recombinant hMIP,
according to SDS PAGE analysis, were concentrated using an
Amicon ﬁltration unit (Millipore Corp.) equipped with a 50 kDa
exclusion membrane, and the recovered protein was ﬁnally stored
in TBS buffer at 70 C.
4.4. Peptide synthesis
Highly sensitive FRET peptides were synthesized by solid-phase
procedures, as described elsewhere [27].
4.5. Synthesis of support-bound FRET peptide library
The syntheses of libraries were carried out manually as previ-
ously described [24]. Brieﬂy, the libraries were synthesized using
1 g of PEGA 1900 resin [28] in a 20 column Teﬂon synthesis
block, using protected Fmoc amino acids. The resin was evenly
distributed in the 20 wells of the Teﬂon synthesis block, and
Fmoc groups were removed. Prior to coupling, the Fmoc amino
acids (1 equiv.) were pre-activated with HOBt (1 equiv.), TBTU
(1 equiv.) and NMM (2 equiv.) in DMF (1 ml) for 6 min; on the
activated amino acids were added to each of the 20 wells.
After the completion of the coupling, the block was ﬁlled with
DMF up to 1 cm above the top of the wells and inverted. Then,
the resin was mixed vigorously by agitation for 30 min in the
mixing chamber. The block was again inverted, evenly distribut-
ing the resin in the wells for washing and removal of Fmoc
group. This procedure was repeated for the incorporation of all
the randomized positions. After the randomized positions, the
Fmoc-K (Abz-Boc) and Fmoc-K (Dnp) were incorporated. The side
chain protecting groups were removed by treatment with a mix-
ture of TFA:thioanisole:ethane dithiol:water (87:5:5:3) for 8 h.
The resin was washed with 95% acetic acid (4), DMF (4),
5%DIPEA in DMF (3), DMF (3), DCM (6) and ﬁnally dried
under vacuum.4.6. Support-bound FRET peptide library screening
The peptide library screening was carried out as previously
described [24]. For all assays, the library beads were washed with
water (3) and the assay buffer (3) before the addition of the
enzyme. The reactions were stopped by dilution with 3 M HCl,
and the mixtures were washed thoroughly until pH 5.6 was
reached. The beads were transferred to a glass dish and inspected
by ﬂuorescence microscopy (Stereo microscope Stemi-Zeiss), and
the ﬂuorescent beads were collected and transferred to a
TFA-treated cartridge ﬁlter for on-resin sequence analysis. The
amino acid sequence and cleavage site were determined by
Edman degradation using a PPSQ/23 protein sequencer
(Shimadzu, Japan). hMIP was assayed as follows: 0.5 lM of enzyme
was mixed with 50 mg of resin 50 mM Tris, 100 mM NaCl,
pH 8.0, at 25 C for 24 h. The identiﬁed peptide sequences
susceptible to hydrolysis by hMIP were synthesized as FRET
Abz-peptidyl-Q-EDDnp peptides and assayed in solution with the
enzyme.
4.7. Enzymatic activity assay
Hydrolysis of the FRET peptides used as substrates for hMIP was
monitored spectroﬂuorometrically in a Shimadzu RF-5301PC spec-
troﬂuorometer with excitation and emission wavelengths of 320
and 420 nm, respectively. The rate of increase in ﬂuorescence
was converted into moles of substrate hydrolysed per second,
based on the ﬂuorescence curves of standard peptide solutions,
before and after total enzymatic hydrolysis. The enzyme concen-
tration for initial rate determinations was chosen so that <10% of
the substrate was hydrolysed. The activity was measured in the
absence or in the presence of the assayed inhibitors [16].
4.8. Determination of peptide cleavage sites
The peptide cleavage sites were identiﬁed using mass spec-
trometry (LCMS-2010 EV Shimadzu, Tokyo, Japan) and/or peptide
sequencing, using a PPSQ-23 protein sequencer (Shimadzu,
Tokyo, Japan) [16].
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